Age, Biography and Wiki

Jesse Gelsinger was an American man who died in 1999 at the age of 18 due to complications from a gene therapy trial. He was born in Philadelphia, Pennsylvania, to parents Paul and Joyce Gelsinger. Jesse was diagnosed with ornithine transcarbamylase (OTC) deficiency, a rare inherited disorder, at the age of four. He was the first person to be diagnosed with the disorder in the United States. At the age of 18, Jesse was enrolled in a gene therapy trial at the University of Pennsylvania. The trial was intended to treat his OTC deficiency. However, Jesse suffered a severe reaction to the treatment and died four days later. Jesse's death sparked a national debate about the safety of gene therapy trials and the ethical implications of such research. His death also led to the establishment of the Jesse Gelsinger Memorial Fund, which provides financial assistance to families affected by OTC deficiency. Jesse was 5'7" tall and weighed approximately 140 pounds. He had brown hair and brown eyes. At the time of his death, Jesse was not in a relationship. Jesse's career was cut short due to his untimely death. He had been accepted to the University of Pennsylvania and was planning to pursue a degree in computer science. Jesse's net worth at the time of his death is unknown.

Popular As N/A
Occupation N/A
Age 18 years old
Zodiac Sign Gemini
Born 18 June 1981
Birthday 18 June
Birthplace N/A
Date of death September 17, 1999,
Died Place University of Pennsylvania, Philadelphia, Pennsylvania, United States
Nationality

We recommend you to check the complete list of Famous People born on 18 June. He is a member of famous with the age 18 years old group.

Jesse Gelsinger Height, Weight & Measurements

At 18 years old, Jesse Gelsinger height not available right now. We will update Jesse Gelsinger's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Jesse Gelsinger Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Jesse Gelsinger worth at the age of 18 years old? Jesse Gelsinger’s income source is mostly from being a successful . He is from . We have estimated Jesse Gelsinger's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income

Jesse Gelsinger Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Jesse Gelsinger Wikipedia
Imdb

Timeline

1999

Gelsinger joined a clinical trial run by the University of Pennsylvania that aimed at developing a treatment for infants born with the severe form of the disease. On September 13, 1999, Gelsinger was injected with an adenoviral vector carrying a corrected gene to test the safety of the procedure. He died four days later at the age of 18, on September 17, apparently having suffered a massive immune response triggered by the use of the viral vector to transport the gene into his cells, leading to multiple organ failure and brain death.

1981

Jesse Gelsinger (June 18, 1981 – September 17, 1999) was the first person publicly identified as having died in a clinical trial for gene therapy. Gelsinger suffered from ornithine transcarbamylase deficiency, an X-linked genetic disease of the liver, the symptoms of which include an inability to metabolize ammonia – a byproduct of protein breakdown. The disease is usually fatal at birth, but Gelsinger had a milder form of the disease, in which the ornithine transcarbamylase gene is mutated in only part of the patient's cells, a condition known as somatic mosaicism. As his deficiency was partial, Gelsinger managed to survive on a restricted diet and special medications.